ImageneBio (IMA) Change in Acquisitions & Divestments (2022 - 2025)
ImageneBio (IMA) posted Change in Acquisitions & Divestments of -$68.8 million for Q3 2025, down 196.83% sequentially from $71.1 million in Q2 2025, and down 303.63% YoY from $33.8 million in Q3 2024.
ImageneBio (IMA) Change in Acquisitions & Divestments (2022 - 2025) Analysis & Trends
ImageneBio has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at -$68.8 million in Q3 2025.
- Quarterly Change in Acquisitions & Divestments fell 303.63% year-over-year to -$68.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $52.6 million (down 5.52% YoY) and the FY2024 annual result came in at $60.5 million, down 60.9% from the prior year.
- Change in Acquisitions & Divestments fell to -$68.8 million in Q3 2025 per IMA's latest filing, from $71.1 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $71.1 million in Q2 2025 and troughed at -$68.8 million in Q3 2025.
- A 4-year average of $25.5 million and a median of $34.1 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
- The widest YoY moves for Change in Acquisitions & Divestments: up 418.72% in 2025, down 303.63% in 2025.
- Over 4 years, Change in Acquisitions & Divestments stood at $37.2 million in 2022, then gained by 22.23% to $45.5 million in 2023, then climbed by 10.63% to $50.3 million in 2024, then sank by 236.78% to -$68.8 million in 2025.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered -$68.8 million, $71.1 million, and $50.3 million for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | ImageneBio | 47.79 Mn | -87.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -68.82 Mn |
| Sep 30, 2025 | -68.82 Mn |
| Jun 30, 2025 | 71.07 Mn |
| Jun 30, 2025 | 71.07 Mn |
| Dec 31, 2024 | 50.31 Mn |
| Dec 31, 2024 | 50.31 Mn |
| Sep 30, 2024 | -17.05 Mn |
| Sep 30, 2024 | -17.05 Mn |
| Jun 30, 2024 | 13.70 Mn |
| Jun 30, 2024 | 13.70 Mn |
| Mar 31, 2024 | 13.50 Mn |
| Mar 31, 2024 | 13.50 Mn |
| Dec 31, 2023 | 45.48 Mn |
| Dec 31, 2023 | 45.48 Mn |
| Sep 30, 2023 | 50.06 Mn |
| Sep 30, 2023 | 50.06 Mn |
| Jun 30, 2023 | 28.00 Mn |
| Jun 30, 2023 | 28.00 Mn |
| Mar 31, 2023 | 31.07 Mn |
| Mar 31, 2023 | 31.07 Mn |